CANAQUEST ANNOUNCES MENTABINOL® A SCIENTIFIC DISCOVERY, AS PUBLISHED IN THE JOURNAL OF NEUROSCIENCE

    NEXT STORY
    Akari Therapeutics Announces Publication in American Journal of Pathology Highlighting Potential of Nomacopan in Treatment of Uveitis and Retinal Disease
    PREV STORY
    Allied Corp. Strengthens National Brand Support with the Signing of Elite Athlete David Lipson
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Intercept to Report 2017 Full Year Financial Results on February 14 and Present at Upcoming Conferences

    NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Data on Rafael Pharmaceuticals’ CPI-613® (devimistat) in Patients with Relapsed Burkitt Lymphoma to be Presented at the 2019 American Society of Hematology (ASH) Annual Meeting & Exposition

    author_avatar
    NASDAQ Market News

    ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®

    author_avatar
    NASDAQ Market News